PRECLINICAL COMBINATION OF A NOVEL IRE1 RNASE INHIBITOR MKC-8866 AND TYROSINE KINASE INHIBITION ACTS SYNERGISTIC IN ACUTE LYMPHOBLASTIC LEUKEMIA - Archive ouverte HAL Access content directly
Journal Articles Haematologica Year : 2017

PRECLINICAL COMBINATION OF A NOVEL IRE1 RNASE INHIBITOR MKC-8866 AND TYROSINE KINASE INHIBITION ACTS SYNERGISTIC IN ACUTE LYMPHOBLASTIC LEUKEMIA

, , , , (1, 2) , , ,
1
2
M. Vieri
  • Function : Author
A. Salimi
  • Function : Author
J. B. Patterson
  • Function : Author
A. Samali
  • Function : Author
T. H. Bruemmendorf
  • Function : Author
I. Appelmann
  • Function : Author
B. Kharabi
  • Function : Author

Abstract

no abstract
Not file

Dates and versions

hal-01585927 , version 1 (12-09-2017)

Identifiers

  • HAL Id : hal-01585927 , version 1

Cite

M. Vieri, A. Salimi, J. B. Patterson, A. Samali, E. Chevet, et al.. PRECLINICAL COMBINATION OF A NOVEL IRE1 RNASE INHIBITOR MKC-8866 AND TYROSINE KINASE INHIBITION ACTS SYNERGISTIC IN ACUTE LYMPHOBLASTIC LEUKEMIA. Haematologica, 2017, 102, pp.338--338. ⟨hal-01585927⟩
56 View
0 Download

Share

Gmail Facebook Twitter LinkedIn More